HEKO PHARMACY LTD — Captopril Importer Profile
Pharmaceutical Importer · #3 buyer for Captopril · $315.2K import value · 10 shipments · TANZANIA · DGFT Verified
HEKO PHARMACY LTD is the #3 importer of Captopril from India with $315.2K in import value and 10 verified shipments. HEKO PHARMACY LTD holds a 2.7% market share in Captopril imports based in TANZANIA. The company sources from 1 verified supplier across 7 formulations shipped to 1 country.
HEKO PHARMACY LTD — Captopril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Captopril to HEKO PHARMACY LTD?
Verified from 10 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| LINCOLN PHARMACEUTICALS LIMITED | $315.2K | 10 | 100.0% |
HEKO PHARMACY LTD sources Captopril from 1 verified Indian supplier based on 10 customs records. The primary supplier is LINCOLN PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does HEKO PHARMACY LTD Compare to Nearest Captopril Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AJANTA PHARMA USA INC. C/O RXCROSSR | UNITED STATES | $1.1M | 42 | $27.3K |
| 3 | HEKO PHARMACY LTD ★ | TANZANIA | $336.7K | 10 | $33.7K |
| 5 | UNIQUE PHARMA, | CONGO DR | $232.1K | 5 | $46.4K |
| 4 | M.S.D | TANZANIA | $200.0K | 4 | $50.0K |
HEKO PHARMACY LTD ranks #3 among 170 Captopril importers from India. Average shipment value of $33.7K compared to the market average of $17.2K. The closest competitors by value are AJANTA PHARMA USA INC. C/O RXCROSSR and UNIQUE PHARMA,.
Where Does HEKO PHARMACY LTD Import Captopril To?
Destination countries from 10 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $315.2K | 10 | 100.0% |
HEKO PHARMACY LTD imports Captopril to 1 country. The primary destination is TANZANIA receiving 100.0% of shipments worth $315.2K.
What Captopril Formulations Does HEKO PHARMACY LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| Captopril Tablets BP 25 mg (Capril-25) ( | $109.0K | 4 |
| Captopril Tablets BP (Capril-25)(37169X1 | $50.0K | 1 |
| CAPTOPRIL TABLETS BP 25 MG (CAPRIL-25)(36804 X 10X10 TAB) | $50.0K | 1 |
| Captopril Tablets BP (Capril-25)(24488X1 | $40.4K | 1 |
| Captopril Tablets BP (Capril-25) (24043X | $39.4K | 1 |
| CAPTOPRIL TABLETS BP 25 MG (CAPRIL-25) (1124310X10 TAB)NOS | $18.4K | 1 |
| Captopril Tablets BP (Capril-25) (4800X1 | $7.9K | 1 |
HEKO PHARMACY LTD imports 7 distinct Captopril formulations from India. The top formulation is Captopril Tablets BP 25 mg (Capril-25) ( with 4 shipments worth $109.0K.
Who Are the Top Buyers of Captopril from India and How Much Does HEKO PHARMACY LTD Import?
India exported $2.9M worth of Captopril through 517 shipments from 109 suppliers to 63 countries, serving 170 buyers globally. HEKO PHARMACY LTD imports $315.2K of this total, accounting for 2.7% of India's Captopril exports with 10 shipments from TANZANIA. This is verified from 10 customs shipment records covering 7 distinct formulations.
What Is the Average Order Value for HEKO PHARMACY LTD's Captopril Imports?
HEKO PHARMACY LTD's average Captopril order value is $31.5K per consignment, based on 10 shipments totaling $315.2K. HEKO PHARMACY LTD is based in TANZANIA and ranks #3 among all Captopril importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Captopril to HEKO PHARMACY LTD?
HEKO PHARMACY LTD sources Captopril from 1 verified Indian supplier: LINCOLN PHARMACEUTICALS LIMITED ($315.2K, 100.0%). This is based on 10 customs records.
How Does HEKO PHARMACY LTD Compare to Other Captopril Importers?
HEKO PHARMACY LTD ranks #3 among 170 Captopril importers from India with a 2.7% market share. The top 3 importers are AJANTA PHARMA USA INC. C/O RXCROSSR ($1.1M), HEKO PHARMACY LTD ($336.7K), UNIQUE PHARMA, ($232.1K). HEKO PHARMACY LTD processed 10 shipments from TANZANIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Captopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Captopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: HEKO PHARMACY LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as HEKO PHARMACY LTD's capped import value divided by total capped export value for Captopril across all Indian exporters.
- 5.Verified Records: This page is backed by 10 individual customs records matching HEKO PHARMACY LTD importing Captopril, covering 7 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 63+ countries, 170+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Captopril Import Data for HEKO PHARMACY LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for HEKO PHARMACY LTD's Captopril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
HEKO PHARMACY LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
HEKO PHARMACY LTD × Captopril
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for HEKO PHARMACY LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Captopril. For current order-level data, contact TransData Nexus.